National guidelines 3 highlight this issue and state that the alternative, direct puncture technique, has not been demonstrated to result in metastases, but they do not go as far as to make recommendations for clinical practice. Most recently a prospective trial has attempted to address this question. 4 Ellrichmann et al performed immediate and delayed (after 3-6 months) cytology from PEG tubing and at the transcutaneous incision site of 40 patients undergoing pull-through PEG for ear nose and throat (ENT)/oeosphageal cancer. The results were concerning, demonstrating malignant cells on cytology of 22.5% of patients immediately after pullthrough PEG placement, and 9.4% of patients with local metastases at follow up. While the authors admit the sample size was small (n=7 studied at follow up), the study demonstrated a shorter median overall survival in those with proof of malignant cells at follow up (16.1 weeks vs 26.8 weeks, p=0.08). The authors note that risk of malignant seeding was highest in older patients and in those with higher tumour stages and concluded that pullthrough PEG should be avoided in these groups and direct access gastrostomy favoured instead.
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under the heading of 'service evaluation' . It seems 'designed and conducted solely to define or judge current care' . It clearly complies with 'usually involves analysis of existing data but may include administration of interview or questionnaire' .
It is a general point that many of the projects submitted by trainees for REC approval could be classified either under this heading, or as 'clinical audit' -which also does not usually need REC review. If in doubt, the chair of a REC will usually be able to give advice -we're just as happy as the researcher to keep paperwork to a minimum. This is my personal opinion -I do not speak for NRES!
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PEG placement for patients with oropharyngeal/oeosphageal cancers
Editor -I recently read and completed the CME gastroenterology self-assessment questionnaire (Clin Med Dec 2012 pp 572-95). Question 3 asks about nutritional support for a patient with a pharyngeal tumour due to undergo radiotherapy and surgery. The answer given is that he should have a percutaneous endoscopic gastrostomy (PEG) sited for feeding. Endoscopic siting of a PEG tube involves pulling the feeding tube and plastic 'bumper' through the oropharynx, oeosphagus, into the stomach and out through the gastrostomy site. This procedure potentially brings the tube and bumper into direct contact with tumours at these sites. Tumour seeding with development of metastases at the PEG site has been reported in numerous case reports 1, 2 and metastases of this nature can have devastating consequences for patients.
